Investors Asset Management of Georgia’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.45M Buy
19,079
+478
+3% +$55.9K 0.85% 33
2026
Q1
$2.24M Buy
18,601
+478
+3% +$55.2K 0.92% 34
2025
Q4
$1.91M Sell
18,123
-47
-0.3% -$4.41K 0.79% 36
2025
Q3
$1.53M Buy
18,170
+379
+2% +$31.2K 0.65% 48
2025
Q2
$1.41M Sell
17,791
-506
-3% -$40.2K 0.65% 46
2025
Q1
$1.64M Sell
18,297
-69
-0.4% -$6.44K 0.83% 32
2024
Q4
$1.83M Sell
18,366
-197
-1% -$20.3K 0.89% 29
2024
Q3
$2.11M Buy
18,563
+2
+0% +$238 0.99% 24
2024
Q2
$2.3M Sell
18,561
-97
-0.5% -$12.5K 1.12% 18
2024
Q1
$2.46M Sell
18,658
-902
-5% -$111K 1.16% 18
2023
Q4
$2.13M Buy
19,560
+1,067
+6% +$111K 1.08% 21
2023
Q3
$1.88M Hold
18,493
1.04% 21
2023
Q2
$2.13M Hold
18,493
1.1% 17
2023
Q1
$1.97M Sell
18,493
-1,600
-8% -$173K 1.05% 19
2022
Q4
$2.23M Sell
20,093
-94
-0.5% -$9.61K 1.16% 18
2022
Q3
$1.74M Sell
20,187
-50
-0.2% -$4.46K 0.9% 23
2022
Q2
$1.84M Hold
20,237
0.96% 21
2022
Q1
$1.66M Sell
20,237
-375
-2% -$29.6K 0.84% 30
2021
Q4
$1.58M Buy
20,612
+1,500
+8% +$119K 0.75% 30
2021
Q3
$1.44M Buy
19,112
+1
+0% +$76 0.75% 34
2021
Q2
$1.49M Sell
19,111
-1,048
-5% -$78K 0.8% 32
2021
Q1
$1.48M Buy
20,159
+1,607
+9% +$119K 0.86% 32
2020
Q4
$1.45M Sell
18,552
-2,174
-10% -$166K 0.98% 23
2020
Q3
$1.64M Buy
20,726
+1,677
+9% +$131K 1.1% 17
2020
Q2
$1.41M Sell
19,049
-53
-0.3% -$3.99K 0.98% 25
2020
Q1
$1.4M Sell
19,102
-3,170
-14% -$249K 1.15% 17
2019
Q4
$1.93M Sell
22,272
-516
-2% -$42.4K 1.17% 19
2019
Q3
$1.83M Hold
22,788
1.17% 15
2019
Q2
$1.82M Sell
22,788
-328
-1% -$25.1K 1.23% 17
2019
Q1
$1.83M Sell
23,116
-183
-0.8% -$13.7K 1.28% 15
2018
Q4
$1.7M Sell
23,299
-262
-1% -$18.5K 1.39% 13
2018
Q3
$1.59M Sell
23,561
-403
-2% -$25.7K 1.11% 21
2018
Q2
$1.39M Buy
23,964
+87
+0.4% +$4.91K 1.02% 23
2018
Q1
$1.24M Buy
23,877
+37
+0.2% +$2K 0.92% 25
2017
Q4
$1.28M Sell
23,840
-277
-1% -$15.4K 0.91% 25
2017
Q3
$1.47M Sell
24,117
-981
-4% -$59.5K 1.08% 20
2017
Q2
$1.53M Sell
25,098
-980
-4% -$59.7K 1.06% 16
2017
Q1
$1.58M Buy
26,078
+136
+0.5% +$8.25K 1.1% 15
2016
Q4
$1.46M Buy
25,942
+750
+3% +$43.9K 1.08% 16
2016
Q3
$1.5M Sell
25,192
-412
-2% -$24.1K 1.14% 16
2016
Q2
$1.41M Buy
25,604
+105
+0.4% +$5.59K 1.1% 16
2016
Q1
$1.29M Hold
25,499
1.07% 17
2015
Q4
$1.28M Sell
25,499
-105
-0.4% -$5.29K 1.08% 17
2015
Q3
$1.21M Hold
25,604
1.08% 16
2015
Q2
$1.39M Sell
25,604
-26
-0.1% -$1.46K 1.19% 14
2015
Q1
$1.41M Hold
25,630
1.16% 15
2014
Q4
$1.39M Buy
+25,630
New +$1.43M 1.2% 15

Other funds holding MRK

Investors Asset Management of Georgia's MRK Position: Q2 2026 in Review

Investors Asset Management of Georgia increased its Merck (MRK) stake by 2.6% in Q2 2026, buying an estimated $55.9K and bringing the position to 19,079 shares worth $2.45M. The position accounts for 0.85% of the portfolio, ranked #33.

Investors Asset Management of Georgia first reported a position in MRK in Q4 2014 and has held it in 47 quarters since. The position peaked at $2.46M in Q1 2024. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Investors Asset Management of Georgia held 19,079 shares of Merck worth $2.45M as of Q2 2026.
  • Investors Asset Management of Georgia bought 478 Merck shares in Q2 2026, an estimated $55.9K.
  • Merck made up 0.85% of Investors Asset Management of Georgia's portfolio in Q2 2026, its #33 holding.
  • Investors Asset Management of Georgia first reported a position in Merck in Q4 2014 and has held it in 47 quarters since.
  • Investors Asset Management of Georgia's Merck position peaked at $2.46M in Q1 2024.
  • 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Investors Asset Management of Georgia's 13F filing for Q2 2026, filed 22 Jul 2026.